Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)
Others
Ratios

Benitec Biopharma (BNTC) Non Operating Income (2019 - 2025)

Benitec Biopharma's Non Operating Income history spans 7 years, with the latest figure at $834000.0 for Q1 2025.

  • For Q1 2025, Non Operating Income rose 5312.5% year-over-year to $834000.0; the TTM value through Mar 2025 reached $2.7 million, up 520.53%, while the annual FY2024 figure was -$204000.0, 57.59% up from the prior year.
  • Non Operating Income for Q1 2025 was $834000.0 at Benitec Biopharma, down from $1.3 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $1.3 million in Q4 2024 and bottomed at -$531000.0 in Q2 2023.
  • The 5-year median for Non Operating Income is -$35500.0 (2022), against an average of $84125.0.
  • The largest annual shift saw Non Operating Income plummeted 2033.33% in 2021 before it surged 7931.25% in 2024.
  • A 5-year view of Non Operating Income shows it stood at $14000.0 in 2021, then soared by 1321.43% to $199000.0 in 2022, then tumbled by 108.04% to -$16000.0 in 2023, then soared by 7931.25% to $1.3 million in 2024, then crashed by 33.44% to $834000.0 in 2025.
  • Per Business Quant, the three most recent readings for BNTC's Non Operating Income are $834000.0 (Q1 2025), $1.3 million (Q4 2024), and $732000.0 (Q3 2024).